Roger Crystal is a biopharma executive and clinician, best known as the founder and former CEO of Opiant Pharmaceuticals, where he led the development and approval of NARCAN® Nasal Spray. He has a background as a surgeon and holds an MBA from London Business School, now serving on several boards, including MindMed.
His primary passion is combating the opioid crisis, a cause that drove the creation of NARCAN and his continued work in developing treatments for addiction and overdose. He is actively involved in advocacy, participating in initiatives like the National Fentanyl Awareness Day, reflecting a deep commitment to addressing public health crises.
He started Opiant Pharmaceuticals from the bedroom of his London apartment in 2009 while working a full-time job in management consulting.
Read the full overview →They are quite likely to negotiate on pricing or other key terms. They choose to analyze logically and value facts to emotions. They don’t appreciate bells and whistles unless backed by data.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.